Behçet’s Disease: An Overview of Etiopathogenesis

Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathie...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 10; p. 1067
Main Authors Leccese, Pietro, Alpsoy, Erkan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 10.05.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by , may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
AbstractList Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by , may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B*51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B*51, may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B*51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by mucocutaneous lesions and ocular involvement. BD shares some common features with autoimmune and autoinflammatory diseases and spondyloarthropathies (MHC-I-opathies). It is related to more than one pathogenic pathway triggered by environmental factors such as infectious agents in genetically predisposed subjects. The interplay between genetic background and immune system is linked to the BD presentation. Genetic factors have been investigated extensively, and several recent genome-wide association studies have confirmed HLA-B * 51 to be the strongest genetic susceptibility factor. However, new non-HLA susceptibility genes have been identified. Genetic variations in the genes encoding the cytokines could affect their function and be associated with disease susceptibility. Infectious agents such as Streptococcus sanguinis or the differences in salivary or gut microbiome composition can be considered to trigger the innate-derived inflammation, which is, subsequently, sustained by adaptive immune responses. Altered trimming of microbial and/or endogenous peptides by endoplasmic reticulum aminopeptidase 1 (ERAP1), presented by HLA-B * 51 , may play a key role in BD pathogenesis causing an alteration in T cell balance with downregulation of Tregs and expansion of Th1 and Th17. The activity of neutrophils is increased and there is an intense neutrophil infiltration in the early stage of inflammation in organs affected by the disease. Association with HLA-B * 51 and increased IL-17 response seems to have an important role in neutrophil activity. In this paper, we provide an overview of the most recent advances on BD etiopathogenesis.
Author Alpsoy, Erkan
Leccese, Pietro
AuthorAffiliation 2 Department of Dermatology and Venereology, School of Medicine, Akdeniz University , Antalya , Turkey
1 Rheumatology Institute of Lucania (IRel) and the Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera , Potenza , Italy
AuthorAffiliation_xml – name: 2 Department of Dermatology and Venereology, School of Medicine, Akdeniz University , Antalya , Turkey
– name: 1 Rheumatology Institute of Lucania (IRel) and the Rheumatology Department of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera , Potenza , Italy
Author_xml – sequence: 1
  givenname: Pietro
  surname: Leccese
  fullname: Leccese, Pietro
– sequence: 2
  givenname: Erkan
  surname: Alpsoy
  fullname: Alpsoy, Erkan
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31134098$$D View this record in MEDLINE/PubMed
BookMark eNp1kU1uFDEQhS0URELInhXqJZsZ_NdumwVSSAJEipQNrK1qu3rGUXd7sHsGseMaOQEH4SacBM9MghIkvLFVfu-rUr3n5GCMIxLyktG5ENq86cIwrOecMjOnjKrmCTliSsmZ4FwePHgfkpOcb2g50ggh6mfkUDAmJDX6iMj3uPz1E6ffP25zdR4yQsa31elYXW8wbQJ-q2JXXUwhrmBaxgWOmEN-QZ520Gc8ubuPyZcPF5_PPs2urj9enp1ezZxUfJoZMLWgnmOnJGgptQEqtOLAsNPeY82MBuV02-gWOkTZcsZU41vPpMdWi2Nyuef6CDd2lcIA6buNEOyuENPCQpqC69HWQjGvGyqUc5J1AIY1blvyBqXybWG927NW63ZA73CcEvSPoI9_xrC0i7ixquaCUlUAr-8AKX5dY57sELLDvocR4zpbzkUZn5atF-mrh73-NrlfexGovcClmHPCzrowQdnytnXoLaN2G7HdRWy3EdtdxMVI_zHes_9r-QOEJ6tU
CitedBy_id crossref_primary_10_3390_ijms24043160
crossref_primary_10_1002_jvc2_11
crossref_primary_10_1007_s10067_021_05817_1
crossref_primary_10_2139_ssrn_3903947
crossref_primary_10_3389_fimmu_2022_888763
crossref_primary_10_1016_j_intimp_2024_112122
crossref_primary_10_1186_s41927_024_00382_x
crossref_primary_10_1080_09638288_2023_2283104
crossref_primary_10_1038_s41598_025_87130_4
crossref_primary_10_1016_j_clim_2023_109304
crossref_primary_10_1186_s43042_024_00605_3
crossref_primary_10_1111_bjd_20643
crossref_primary_10_1016_j_intimp_2022_108825
crossref_primary_10_3389_fcell_2021_758240
crossref_primary_10_1016_j_clim_2021_108854
crossref_primary_10_1016_j_semarthrit_2023_152224
crossref_primary_10_3389_fmolb_2021_797689
crossref_primary_10_1007_s10787_020_00701_x
crossref_primary_10_1097_MD_0000000000031173
crossref_primary_10_1371_journal_pone_0227836
crossref_primary_10_1016_j_medcle_2022_08_009
crossref_primary_10_1016_j_nic_2023_07_007
crossref_primary_10_1055_a_2249_2116
crossref_primary_10_1016_j_clindermatol_2021_05_023
crossref_primary_10_1111_iji_12623
crossref_primary_10_1186_s12886_021_02222_9
crossref_primary_10_3390_jcm10215174
crossref_primary_10_3389_fimmu_2020_00358
crossref_primary_10_1080_00325481_2022_2159205
crossref_primary_10_3389_fimmu_2021_769785
crossref_primary_10_7759_cureus_68236
crossref_primary_10_1111_ijcp_14638
crossref_primary_10_1186_s13023_021_02056_0
crossref_primary_10_1007_s10753_023_01950_y
crossref_primary_10_1016_j_intimp_2023_110128
crossref_primary_10_1097_RHU_0000000000001575
crossref_primary_10_3389_fmicb_2024_1416614
crossref_primary_10_2147_JEP_S265645
crossref_primary_10_1007_s40123_023_00767_0
crossref_primary_10_1111_dth_15616
crossref_primary_10_3389_fphar_2023_1110741
crossref_primary_10_1016_j_ajoc_2022_101630
crossref_primary_10_5114_reum_2022_117843
crossref_primary_10_1002_advs_202411524
crossref_primary_10_1097_GH9_0000000000000457
crossref_primary_10_3389_fmed_2021_624795
crossref_primary_10_1007_s40257_021_00609_4
crossref_primary_10_1093_rheumatology_kead101
crossref_primary_10_1111_dth_15585
crossref_primary_10_1007_s40674_020_00143_0
crossref_primary_10_1016_j_autrev_2020_102613
crossref_primary_10_1186_s13023_021_01772_x
crossref_primary_10_1111_jdv_16454
crossref_primary_10_59213_TP_2024_169
crossref_primary_10_1097_MD_0000000000031277
crossref_primary_10_15789_1563_0625_EOH_2286
crossref_primary_10_3389_fimmu_2021_648341
crossref_primary_10_1590_1677_5449_20220036
crossref_primary_10_1007_s10238_023_01173_3
crossref_primary_10_1002_msc_1632
crossref_primary_10_1111_jop_13320
crossref_primary_10_3390_ijms21165803
crossref_primary_10_1080_14728214_2020_1847271
crossref_primary_10_1080_08830185_2020_1845330
crossref_primary_10_1186_s13075_022_02938_z
crossref_primary_10_1007_s11910_020_01088_6
crossref_primary_10_1159_000510212
crossref_primary_10_1016_j_amsu_2020_03_010
crossref_primary_10_3389_fcell_2021_719235
crossref_primary_10_1002_wrna_1806
crossref_primary_10_3390_jcm11051278
crossref_primary_10_1080_09273948_2021_1889610
crossref_primary_10_2147_TCRM_S232660
crossref_primary_10_1055_a_1958_2338
crossref_primary_10_1080_03009742_2021_1885735
crossref_primary_10_21926_obm_genet_2403261
crossref_primary_10_1080_08820139_2021_1883647
crossref_primary_10_1111_tan_13880
crossref_primary_10_3390_ijms24033041
crossref_primary_10_3390_biomedicines11020624
crossref_primary_10_1007_s12026_024_09498_1
crossref_primary_10_1016_j_lfs_2024_122950
crossref_primary_10_3390_ijms25126697
crossref_primary_10_3390_medicina59122163
crossref_primary_10_47936_encephalitis_2020_00059
crossref_primary_10_1016_j_imlet_2021_04_008
crossref_primary_10_3389_fcell_2020_00818
crossref_primary_10_1002_eji_202250181
crossref_primary_10_1097_GH9_0000000000000463
crossref_primary_10_1186_s13075_024_03306_9
crossref_primary_10_1016_j_clim_2023_109631
crossref_primary_10_1155_2021_6626909
crossref_primary_10_1016_j_cyto_2020_154994
crossref_primary_10_3390_ijms242216382
crossref_primary_10_1093_rheumatology_keaa682
crossref_primary_10_3389_fimmu_2024_1361123
crossref_primary_10_1111_hel_12663
crossref_primary_10_1016_j_drudis_2021_11_020
crossref_primary_10_3389_fmed_2021_627192
crossref_primary_10_1007_s10067_021_05755_y
crossref_primary_10_3389_fimmu_2019_02877
crossref_primary_10_3389_fimmu_2019_02755
crossref_primary_10_3389_fimmu_2021_724900
crossref_primary_10_1016_j_jconrel_2021_07_017
crossref_primary_10_3389_fmed_2021_695197
crossref_primary_10_1136_bcr_2019_232056
crossref_primary_10_23736_S2724_5683_21_05847_6
crossref_primary_10_1186_s12974_024_03123_6
crossref_primary_10_1080_09546634_2022_2062281
crossref_primary_10_1111_dth_13122
crossref_primary_10_1016_j_exer_2020_108045
crossref_primary_10_1080_1744666X_2021_1834853
crossref_primary_10_1016_j_medcli_2021_11_009
crossref_primary_10_1002_lipd_12398
crossref_primary_10_1007_s00726_022_03170_4
crossref_primary_10_3389_fphar_2022_912906
crossref_primary_10_1186_s13104_021_05767_6
crossref_primary_10_3389_fmolb_2022_831632
crossref_primary_10_1016_j_semarthrit_2020_05_017
crossref_primary_10_1111_1756_185X_14484
crossref_primary_10_1097_MD_0000000000018443
crossref_primary_10_1016_j_exer_2021_108618
crossref_primary_10_1097_RHU_0000000000001788
crossref_primary_10_3389_fmed_2021_713052
crossref_primary_10_3390_jcm11102938
crossref_primary_10_1016_j_autrev_2021_103016
crossref_primary_10_18481_2077_7566_2022_18_3_96_100
crossref_primary_10_1073_pnas_2204289119
Cites_doi 10.3349/ymj.2012.53.1.35
10.1080/1547691X.2017.1346008
10.1038/ng.3786
10.1007/s00281-015-0502-8
10.1136/annrheumdis-2015-209059
10.1099/00222615-34-1-39
10.1902/jop.1999.70.12.1449
10.1002/art.37708
10.1016/j.autrev.2014.12.009
10.3748/wjg.v13.i21.2983
10.1155/2018/2405150
10.1111/j.1348-0421.1992.tb02083.x
10.1111/j.1468-3083.2008.02678.x
10.1186/1546-0096-11-S1-A184
10.1080/08820139.2017.1306865
10.1038/ng.625
10.1177/2040622314523062
10.1097/BOR.0000000000000003
10.12659/MSM.881720
10.1111/j.1365-2133.2007.08116.x
10.1007/s00296-003-0313-4
10.3349/ymj.1997.38.6.444
10.1038/ng.2551
10.4049/jimmunol.1501742
10.1136/annrheumdis-2011-200288
10.1111/j.1365-2133.2006.07348.x
10.1038/gene.2016.28
10.1167/iovs.07-1390
10.1111/j.1600-0714.2009.00765.x
10.1186/ar3005
10.2174/187152811795564109
10.1038/ng.2520
10.1016/j.imlet.2017.12.008
10.1093/rheumatology/keh311
10.1111/tan.13262
10.1016/j.autrev.2017.12.006
10.1016/j.molimm.2016.08.005
10.1002/art.20334
10.1002/art.39240
10.1016/j.autrev.2014.11.009
10.1073/pnas.1101262108
10.1038/jid.2010.114
10.1111/cei.13049
10.1016/j.jaut.2017.08.002
10.1038/nrrheum.2018.3
10.1038/ng.624
10.1007/s12328-014-0488-0
10.1016/j.clindermatol.2013.11.012
10.1155/2014/581468
10.1136/ard.59.8.622
10.4049/jimmunol.1300598
10.3109/08830189709116842
10.1111/1346-8138.13381
10.3109/09273948.2016.1158276
10.1016/j.jaut.2015.08.013
10.1097/MD.0000000000005516
10.1186/s13075-017-1435-5
10.1186/ar2695
10.1111/bjd.12128
10.1111/j.1365-2249.2011.04543.x
10.1161/CIRCULATIONAHA.115.017738
10.1038/s41598-017-09164-7
10.1093/rheumatology/keh236
10.1038/nrrheum.2015.147
10.1111/cei.12939
10.1111/j.1600-051X.2007.01085.x
10.3346/jkms.2017.32.1.33
10.1002/art.24642
10.1155/2017/1274960
10.1155/2018/4246965
10.1016/j.biopha.2017.04.106
10.1016/j.autrev.2011.11.026
10.1016/j.clim.2016.06.002
10.1097/BOR.0000000000000189
10.1074/jbc.M117.789180
ContentType Journal Article
Copyright Copyright © 2019 Leccese and Alpsoy. 2019 Leccese and Alpsoy
Copyright_xml – notice: Copyright © 2019 Leccese and Alpsoy. 2019 Leccese and Alpsoy
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3389/fimmu.2019.01067
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_5361d87036cc41faa917c61d8d9e46db
PMC6523006
31134098
10_3389_fimmu_2019_01067
Genre Journal Article
Review
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
CGR
CUY
CVF
ECM
EIF
IAO
IEA
IHR
IHW
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-9a9530d2ef64a84489a03862a1ef8dde5198a6c8b78bafee4b21167dbd14deb83
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:07:31 EDT 2025
Thu Aug 21 18:36:45 EDT 2025
Fri Jul 11 15:10:05 EDT 2025
Thu Jan 02 22:59:06 EST 2025
Thu Apr 24 23:05:00 EDT 2025
Tue Jul 01 00:39:34 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords infectious agents
Behçet's disease
genetics
immunology
etiology
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-9a9530d2ef64a84489a03862a1ef8dde5198a6c8b78bafee4b21167dbd14deb83
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Angelo Valerio Marzano, University of Milan, Italy
Reviewed by: Giacomo Emmi, University of Florence, Italy; Fiona Moghaddas, Walter and Eliza Hall Institute of Medical Research, Australia
This article was submitted to Autoimmune and Autoinflammatory Disorders, a section of the journal Frontiers in Immunology
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2019.01067
PMID 31134098
PQID 2232110664
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_5361d87036cc41faa917c61d8d9e46db
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6523006
proquest_miscellaneous_2232110664
pubmed_primary_31134098
crossref_citationtrail_10_3389_fimmu_2019_01067
crossref_primary_10_3389_fimmu_2019_01067
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-10
PublicationDateYYYYMMDD 2019-05-10
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-10
  day: 10
PublicationDecade 2010
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in immunology
PublicationTitleAlternate Front Immunol
PublicationYear 2019
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Akman (B26) 2008; 22
Guasp (B53) 2017; 292
Mumcu (B18) 2004; 43
Ombrello (B49) 2015; 27
Puccetti (B64) 2018; 2018
de Menthon (B33) 2009; 61
Suzuki (B75) 1992; 19
Hamzaoui (B79) 2011; 17
Emmi (B83) 2016; 95
Alpsoy (B1) 2016; 43
Studd (B11) 1991; 34
Lee (B36) 2013; 72
Lehner (B9) 1997; 14
Takeuchi (B43) 2017; 49
Onen (B27) 2003; 23
Giza (B52) 2018; 191
Touzot (B84) 2015; 14
Shimizu (B77) 2012; 168
Becatti (B69) 2016; 33
Chi (B78) 2008; 49
Mizushima (B20) 1988; 15
Consolandi (B32) 2015; 14
Kirino (B37) 2013; 45
Abdolmohammadi (B56) 2017; 32
Takeuchi (B59) 2015; 64
Karacayli (B24) 2009; 38
López de Castro (B48) 2016; 77
Yazici (B8) 2018; 14
Sousa (B58) 2015; 67
Pineton de Chambrun (B29) 2012; 11
Hasan (B72) 2017; 188
Mat (B61) 2014; 32
Gul (B34) 2010; 59
Alpsoy (B2) 2007; 157
Puccetti (B65) 2018; 2018
Ben Ahmed (B76) 2004; 50
Gul (B35) 2014; 26
Kochan (B51) 2011; 108
(B3) 1990; 335
Eksioglu-Demiralp (B68) 2001; 19
Kaneko (B19) 1997; 38
Burillo-Sanz (B62) 2017; 7
Hatemi (B6) 2017; 35
Hou (B38) 2012; 64
Celenligil-Nazliel (B23) 1999; 70
Fei (B41) 2009; 11
Cho (B16) 2010; 28
Hughes (B42) 2013; 45
Yavuz (B71) 2016; 17
Reeves (B50) 2013; 191
Yamaguchi (B73) 2010; 12
Behçet (B10) 1937; 105
Salmaninejad (B45) 2017; 14
Lule (B15) 2017; 84
Togashi (B12) 2011; 10
Cho (B14) 2012; 53
Akman (B22) 2007; 34
Deniz (B67) 2017; 46
Cho (B17) 2013; 168
Sakoda (B81) 2016; 196
Gul (B4) 2015; 37
Perazzio (B70) 2015; 33
Kaneko (B25) 2014; 581468
Huang (B44) 2017; 2017
Kang (B55) 2017; 19
Alpsoy (B21) 2005; 23
Padula (B46) 2018; 2018
Greco (B7) 2018; 17
Ersoy (B28) 2007; 13
Akman (B57) 2006; 155
Ekinci (B80) 2010; 130
Alipour (B63) 2017; 91
Esatoglu (B85) 2016; 34
Hisamatsu (B60) 2014; 7
Zhou (B66) 2013; 11
Treusch (B74) 2004; 43
Takeuchi (B47) 2016; 75
Takeuchi (B82) 2017; 25
McGonagle (B5) 2015; 11
Coit (B31) 2016; 169
Mizuki (B39) 2010; 42
Remmers (B40) 2010; 42
Saleh (B30) 2014; 5
Yokota (B13) 1992; 36
Afkari (B54) 2018; 194
References_xml – volume: 53
  start-page: 35
  year: 2012
  ident: B14
  article-title: New insights in the clinical understanding of Behçet's disease
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.2012.53.1.35
– volume: 14
  start-page: 137
  year: 2017
  ident: B45
  article-title: Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches
  publication-title: J Immunotoxicol
  doi: 10.1080/1547691X.2017.1346008
– volume: 335
  start-page: 1078
  year: 1990
  ident: B3
  article-title: Criteria for diagnosis of Behçet's disease
  publication-title: Lancet.
– volume: 49
  start-page: 438
  year: 2017
  ident: B43
  article-title: Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility
  publication-title: Nat Genet
  doi: 10.1038/ng.3786
– volume: 37
  start-page: 413
  year: 2015
  ident: B4
  article-title: Pathogenesis of Behçet's disease: autoinflammatory features and beyond
  publication-title: Semin Immunopathol
  doi: 10.1007/s00281-015-0502-8
– volume: 75
  start-page: 2208
  year: 2016
  ident: B47
  article-title: A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2015-209059
– volume: 34
  start-page: 39
  year: 1991
  ident: B11
  article-title: Detection of HSV-1 DNA in patients with Behçet's syndrome and in patients with recurrent oral ulcers by the polymerase chain reaction
  publication-title: J Med Microbiol
  doi: 10.1099/00222615-34-1-39
– volume: 35
  start-page: 5
  year: 2017
  ident: B6
  article-title: Behçet's disease: an MHC-I-opathy?
  publication-title: Clin Exp Rheumatol
– volume: 70
  start-page: 1449
  year: 1999
  ident: B23
  article-title: Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease
  publication-title: J Periodontol.
  doi: 10.1902/jop.1999.70.12.1449
– volume: 64
  start-page: 4104
  year: 2012
  ident: B38
  article-title: Identification of a susceptibility locus in STAT4 for Behçet‘s disease in Han Chinese in a genome-wide association study
  publication-title: Arthritis Rheum
  doi: 10.1002/art.37708
– volume: 14
  start-page: 370
  year: 2015
  ident: B84
  article-title: IFNa induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2014.12.009
– volume: 13
  start-page: 2983
  year: 2007
  ident: B28
  article-title: H pylori infection in patients with Behçet's disease
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v13.i21.2983
– volume: 2018
  start-page: 2405150
  year: 2018
  ident: B65
  article-title: MicroRNA expression profiling in Behçet's disease
  publication-title: J Immunol Res
  doi: 10.1155/2018/2405150
– volume: 36
  start-page: 815
  year: 1992
  ident: B13
  article-title: Antibody response to oral streptococci in Behcet's disease
  publication-title: Microbiol Immunol
  doi: 10.1111/j.1348-0421.1992.tb02083.x
– volume: 22
  start-page: 950
  year: 2008
  ident: B26
  article-title: Relationship between periodontal findings and the TNF-alpha Gene 1031T/C polymorphism in Turkish patients with Behçet's disease
  publication-title: J Eur Acad Dermatol Venereol.
  doi: 10.1111/j.1468-3083.2008.02678.x
– volume: 11
  start-page: A184
  year: 2013
  ident: B66
  article-title: OR9-001 - Exome sequencing in monogenic Behçet-like disease
  publication-title: Pediatr Rheumatol Online J
  doi: 10.1186/1546-0096-11-S1-A184
– volume: 46
  start-page: 518
  year: 2017
  ident: B67
  article-title: Th17-Inducing conditions lead to in vitro activation of both Th17 and Th1 responses in Behçet's disease
  publication-title: Immunol Invest
  doi: 10.1080/08820139.2017.1306865
– volume: 42
  start-page: 698
  year: 2010
  ident: B40
  article-title: Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease
  publication-title: Nat Genet
  doi: 10.1038/ng.625
– volume: 5
  start-page: 112
  year: 2014
  ident: B30
  article-title: Update on the therapy of Behçet disease
  publication-title: Ther Adv Chronic Dis
  doi: 10.1177/2040622314523062
– volume: 26
  start-page: 56
  year: 2014
  ident: B35
  article-title: Genetics of Behçet's disease: lessons learned from genomewide association studies
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000003
– volume: 17
  start-page: CR227
  year: 2011
  ident: B79
  article-title: Expression of Th-17 and RORγt mRNA in Behçet's Disease
  publication-title: Med Sci Monit
  doi: 10.12659/MSM.881720
– volume: 157
  start-page: 901
  year: 2007
  ident: B2
  article-title: Clinical features and natural course of Behcet's disease in 661 cases: a multicentre study
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2007.08116.x
– volume: 23
  start-page: 289
  year: 2003
  ident: B27
  article-title: Seroprevalence of Borrelia burgdorferi in patients with Behçet's disease
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-003-0313-4
– volume: 38
  start-page: 444
  year: 1997
  ident: B19
  article-title: Streptococcal infection in the pathogenesis of Behçet's disease and clinical effects of minocycline on the disease symptoms
  publication-title: Yonsei Med J
  doi: 10.3349/ymj.1997.38.6.444
– volume: 45
  start-page: 319
  year: 2013
  ident: B42
  article-title: Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease
  publication-title: Nat Genet
  doi: 10.1038/ng.2551
– volume: 196
  start-page: 2947
  year: 2016
  ident: B81
  article-title: Pathogenic function of herpesvirus entry mediator in experimental autoimmune uveitis by induction of Th1- and Th17-type T cell responses
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1501742
– volume: 72
  start-page: 1510
  year: 2013
  ident: B36
  article-title: Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet's disease
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2011-200288
– volume: 155
  start-page: 350
  year: 2006
  ident: B57
  article-title: TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2006.07348.x
– volume: 17
  start-page: 335
  year: 2016
  ident: B71
  article-title: Dual effects of testosterone in Behçet's disease: implications for a role in disease pathogenesis
  publication-title: Genes Immun
  doi: 10.1038/gene.2016.28
– volume: 49
  start-page: 3058
  year: 2008
  ident: B78
  article-title: Upregulated IL-23 and IL-17 in Behçet patients with active uveitis
  publication-title: Invest Ophthalmol Vis Sci
  doi: 10.1167/iovs.07-1390
– volume: 38
  start-page: 410
  year: 2009
  ident: B24
  article-title: The close association between dental and periodontal treatments and oral ulcer course in Behçet's disease: a prospective clinical study
  publication-title: J Oral Pathol Med.
  doi: 10.1111/j.1600-0714.2009.00765.x
– volume: 12
  start-page: R80
  year: 2010
  ident: B73
  article-title: Natural killer cells control a T-helper 1 response in patients with Behçet's disease
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3005
– volume: 10
  start-page: 164
  year: 2011
  ident: B12
  article-title: Skin prick test with self-saliva in patients with oral aphthoses: a diagnostic pathergy for Behcet's disease and recurrent aphthosis
  publication-title: Inflamm Allergy Drug Targets
  doi: 10.2174/187152811795564109
– volume: 45
  start-page: 202
  year: 2013
  ident: B37
  article-title: Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B-51 and ERAP1
  publication-title: Nat Genet
  doi: 10.1038/ng.2520
– volume: 194
  start-page: 56
  year: 2018
  ident: B54
  article-title: Molecular analysis of interleukin-10 gene polymorphisms in patients with Behçet's disease
  publication-title: Immunol Lett
  doi: 10.1016/j.imlet.2017.12.008
– volume: 43
  start-page: 1275
  year: 2004
  ident: B74
  article-title: Influence of human recombinant interferon-alpha2a (rhIFN-alpha2a) on altered lymphocyte subpopulations and monocytes in Behçet's disease
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keh311
– volume: 2018
  start-page: 13262
  year: 2018
  ident: B46
  article-title: ERAP1 molecular characterization: identification of a de novo allelic variant
  publication-title: HLA
  doi: 10.1111/tan.13262
– volume: 33
  start-page: S85
  year: 2015
  ident: B70
  article-title: Behçet's disease heterogeneity: cytokine production and oxidative burst of phagocytes are altered in patients with severe manifestations
  publication-title: Clin Exp Rheumatol
– volume: 17
  start-page: 567
  year: 2018
  ident: B7
  article-title: Behçet's disease: New insights into pathophysiology, clinical features and treatment options
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2017.12.006
– volume: 77
  start-page: 193
  year: 2016
  ident: B48
  article-title: Molecular and pathogenic effects of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in MHC-I-associated inflammatory disorders: towards a unifying view
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2016.08.005
– volume: 50
  start-page: 2291
  year: 2004
  ident: B76
  article-title: Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behçet's disease
  publication-title: Arthritis Rheum
  doi: 10.1002/art.20334
– volume: 34
  start-page: 3
  year: 2016
  ident: B85
  article-title: Highlights of the 17th International Conference on Behçet's syndrome
  publication-title: Clin Exp Rheumatol
– volume: 67
  start-page: 2742
  year: 2015
  ident: B58
  article-title: Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39240
– volume: 14
  start-page: 269
  year: 2015
  ident: B32
  article-title: Behcet's syndrome patients exhibit specific microbiome signature
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2014.11.009
– volume: 108
  start-page: 7745
  year: 2011
  ident: B51
  article-title: Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1101262108
– volume: 130
  start-page: 2136
  year: 2010
  ident: B80
  article-title: IL-17A has an important role in the acute attacks of Behçet's disease
  publication-title: J Invest Dermatol
  doi: 10.1038/jid.2010.114
– volume: 191
  start-page: 11
  year: 2018
  ident: B52
  article-title: Is Behçet's disease a ‘class 1-opathy’?
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.13049
– volume: 84
  start-page: 87
  year: 2017
  ident: B15
  article-title: Behçet Disease serum is immunoreactive to neurofilament medium which share common epitopes to bacterial HSP-65, a putative trigger
  publication-title: J Autoimmun.
  doi: 10.1016/j.jaut.2017.08.002
– volume: 19
  start-page: 588
  year: 1992
  ident: B75
  article-title: Increased peripheral blood gamma delta1 T cells and natural killer cells in Behçet's disease
  publication-title: J Rheumatol
– volume: 19
  start-page: S19
  year: 2001
  ident: B68
  article-title: Neutrophil activation in Behçet's disease
  publication-title: Clin Exp Rheumatol.
– volume: 14
  start-page: 119
  year: 2018
  ident: B8
  article-title: Behçet syndrome: a contemporary view
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2018.3
– volume: 42
  start-page: 703
  year: 2010
  ident: B39
  article-title: Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet's disease susceptibility loci
  publication-title: Nat Genet
  doi: 10.1038/ng.624
– volume: 7
  start-page: 205
  year: 2014
  ident: B60
  article-title: Diagnosis and management of intestinal Behçet's disease
  publication-title: Clin J Gastroenterol
  doi: 10.1007/s12328-014-0488-0
– volume: 28
  start-page: S31
  year: 2010
  ident: B16
  article-title: Identification of streptococcal proteins reacting with sera from Behçet's disease and rheumatic disorders
  publication-title: Clin Exp Rheumatol
– volume: 32
  start-page: 435
  year: 2014
  ident: B61
  article-title: Behçet's disease as a systemic disease
  publication-title: Clin Dermatol
  doi: 10.1016/j.clindermatol.2013.11.012
– volume: 581468
  year: 2014
  ident: B25
  article-title: A new diagnostic way for Behçet's disease: skin prick with self-saliva
  publication-title: Genet Res Int
  doi: 10.1155/2014/581468
– volume: 59
  start-page: 622
  year: 2010
  ident: B34
  article-title: Familial aggregation of Behçet's disease in Turkey
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.59.8.622
– volume: 23
  start-page: 532
  year: 2005
  ident: B21
  article-title: Behçet's disease: treatment of mucocutaneous lesions
  publication-title: Clin Exp Rheumatol
– volume: 191
  start-page: 35
  year: 2013
  ident: B50
  article-title: Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1300598
– volume: 14
  start-page: 21
  year: 1997
  ident: B9
  article-title: The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease
  publication-title: Int Rev Immunol.
  doi: 10.3109/08830189709116842
– volume: 43
  start-page: 620
  year: 2016
  ident: B1
  article-title: Behçet's disease: A comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions
  publication-title: J Dermatol
  doi: 10.1111/1346-8138.13381
– volume: 15
  start-page: 1029
  year: 1988
  ident: B20
  article-title: Induction of Behçet's disease symptoms after dental treatment and streptococcal antigen skin test
  publication-title: J Rheumatol
– volume: 105
  start-page: 1152
  year: 1937
  ident: B10
  article-title: Uber rezidivierende aphthose, durch ein Virus verursachte Geschwure, am Mund, am Auge, und an den Genitalien
  publication-title: Dermatol Wochenschr
– volume: 25
  start-page: 52
  year: 2017
  ident: B82
  article-title: Analysis of Th cell-related cytokine production in Behçet disease patients with uveitis before and after infliximab treatment
  publication-title: Ocul Immunol Inflamm
  doi: 10.3109/09273948.2016.1158276
– volume: 64
  start-page: 137
  year: 2015
  ident: B59
  article-title: The immunogenetics of Behçet's disease: a comprehensive review
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2015.08.013
– volume: 95
  start-page: 49
  year: 2016
  ident: B83
  article-title: Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease
  publication-title: Medicine.
  doi: 10.1097/MD.0000000000005516
– volume: 19
  start-page: 227
  year: 2017
  ident: B55
  article-title: Behçet's disease risk association fine-mapped on the IL23R-IL12RB2 intergenic region in Koreans
  publication-title: Arthritis Res Ther
  doi: 10.1186/s13075-017-1435-5
– volume: 11
  start-page: R66
  year: 2009
  ident: B41
  article-title: Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2695
– volume: 168
  start-page: 977
  year: 2013
  ident: B17
  article-title: Serum IgA reactivity against GroEL of Streptococcus sanguinis and human heterogeneous nuclear ribonucleoprotein A2/B1 in patients with Behçet disease
  publication-title: Br J Dermatol
  doi: 10.1111/bjd.12128
– volume: 168
  start-page: 68
  year: 2012
  ident: B77
  article-title: Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease
  publication-title: Clin Exp Immunol
  doi: 10.1111/j.1365-2249.2011.04543.x
– volume: 33
  start-page: 302
  year: 2016
  ident: B69
  article-title: Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Behçet disease
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.115.017738
– volume: 7
  start-page: 8453
  year: 2017
  ident: B62
  article-title: Mutational profile of rare variants in inflammasome-related genes in Behçet disease: a next generation sequencing approach
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-09164-7
– volume: 43
  start-page: 1028
  year: 2004
  ident: B18
  article-title: Oral health is impaired in Behçet's disease and is associated with disease severity
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keh236
– volume: 11
  start-page: 731
  year: 2015
  ident: B5
  article-title: ‘MHC-I-opathy’-unified concept for spondyloarthritis and Behçet disease
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2015.147
– volume: 188
  start-page: 311
  year: 2017
  ident: B72
  article-title: Circulating NK cells and their subsets in Behçet's disease
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12939
– volume: 34
  start-page: 485
  year: 2007
  ident: B22
  article-title: Relationship between periodontal findings and Behçet's disease: a controlled study
  publication-title: J Clin Periodontol.
  doi: 10.1111/j.1600-051X.2007.01085.x
– volume: 32
  start-page: 33
  year: 2017
  ident: B56
  article-title: Polymorphisms of promoter region of TNF-α gene in iranian azeri turkish patients with Behçet's disease
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2017.32.1.33
– volume: 61
  start-page: 1287
  year: 2009
  ident: B33
  article-title: HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies
  publication-title: Arthritis Rheum
  doi: 10.1002/art.24642
– volume: 2017
  start-page: 1274960
  year: 2017
  ident: B44
  article-title: The association of chemokine gene polymorphisms with VKH and Behçet's disease in a chinese han population
  publication-title: Biomed Res Int
  doi: 10.1155/2017/1274960
– volume: 2018
  start-page: 4246965
  year: 2018
  ident: B64
  article-title: Gene expression profiling in Behçet's disease indicates an autoimmune component in the pathogenesis of the disease and opens new avenues for targeted therapy
  publication-title: J Immunol Res
  doi: 10.1155/2018/4246965
– volume: 91
  start-page: 526
  year: 2017
  ident: B63
  article-title: Epigenetic alterations in chronic disease focusing on Behçet's disease: review
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2017.04.106
– volume: 11
  start-page: 687
  year: 2012
  ident: B29
  article-title: New insights into the pathogenesis of Behçet's disease
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2011.11.026
– volume: 169
  start-page: 28
  year: 2016
  ident: B31
  article-title: Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behcet's disease
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2016.06.002
– volume: 27
  start-page: 349
  year: 2015
  ident: B49
  article-title: Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics
  publication-title: Curr Opin Rheumatol
  doi: 10.1097/BOR.0000000000000189
– volume: 292
  start-page: 9680
  year: 2017
  ident: B53
  article-title: The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M117.789180
SSID ssj0000493335
Score 2.5559278
SecondaryResourceType review_article
Snippet Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting course of unknown etiology hallmarked predominantly by...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1067
SubjectTerms Aminopeptidases - metabolism
Behcet Syndrome - genetics
Behcet Syndrome - immunology
Behcet Syndrome - pathology
Behçet's disease
etiology
Genetic Predisposition to Disease - genetics
Genetic Variation - genetics
genetics
HLA-B Antigens - genetics
Humans
Immunology
infectious agents
Interleukin-17 - genetics
Interleukin-17 - metabolism
Minor Histocompatibility Antigens - metabolism
Neutrophil Infiltration - immunology
Neutrophils - immunology
Streptococcus - immunology
Streptococcus sanguis
T-Lymphocytes, Regulatory - immunology
Th1 Cells - immunology
Th17 Cells - immunology
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbhMxELaqSEi9VBRKWVqqReqFw5L12ut4uSUlUVSp7YVIuVn-WxJEN4gkrXrjNXgCHoQ34UmYsZMoQQguXL221vrGOzPfjvUNIecFl4wWrsi4dDbjLjcZRDmfFR1Jba6BNod2PlfXYjjil-NyvNXqC--ERXngCFy7ZII6iTJR1nJaaw38wuKQqzwXzqD3hZi3RaY-xryXMVbGuiSwsKpdT29vl3iVq3oTZNN24lCQ6_9Tjvn7Vcmt2DN4TA5WSWPajZs9JHu-eUIexTaSD08J7_nJj-9-8fPrt3n6LlZc3qbdJr25Q0_g79NZnfbBAth-ePYBvdt0fkRGg_77i2G26oaQWS6KRVbpqmS5K3wtuJbAqiqdM-AjmvpagpOCVExqYaXpSKNr77kpsMbijKPceSPZM9JqZo1_TtLKUgoLuPSWca2LSlOTewAT23XW0iakvcZG2ZVUOHas-KSAMiCaKqCpEE0V0EzI682Kz1Em4y9zewj3Zh4KXIcBMLtamV39y-wJebU2loIPAqscuvGz5VxBvoOkVgiekONovM2rGKUMCK1MSGfHrDt72X3STCdBdFvg7_NcvPgfmz8h-whHFkRgT0lr8WXpX0JuszBn4Rj_Aus2-NQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Behçet’s Disease: An Overview of Etiopathogenesis
URI https://www.ncbi.nlm.nih.gov/pubmed/31134098
https://www.proquest.com/docview/2232110664
https://pubmed.ncbi.nlm.nih.gov/PMC6523006
https://doaj.org/article/5361d87036cc41faa917c61d8d9e46db
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELZKKyQuiDcpUAUJCXFwGz_W6yChqoWWCqlwYaW9WX6lXdQmdB8t_UX8EP5YZ5x0YatVxSUHx06ceXjm8zgzhLzhUgvGA6dSB09lKBwFKxcp72vmCwuwOZXzOfyqDgbyy7A3_Pt7dEfAyVJoh_WkBuOTzV9nl9ug8B8QcYK93apGp6czPKVVbqaMaHfIGtilPqrpYefs_2h9YSFSxU2mlKQgybKNWy59yIKdSun8l_mgN49S_mOb9h-Q-51Tme-0UvCQrMT6Ebnblpm8fEz4bjz-8ztO307yT2085n2-U-ffznGdiBd5U-V7wB8sTtwc4do3mjwhg_297x8PaFcrgXqp-JSWtuyJIvBYKWk1YK7SFgLQimWx0rCEgaOmrfLa9bWzVYzScYzABBeYDNFp8ZSs1k0dn5O89IzBAKmjF9JaXlrmiqiCw2KelfYZ2bqmjPFdInGsZ3FiAFAgLU2ipUFamkTLjLybj_jZJtG4pe8uEnveD9Nfp4ZmfGQ6bTI9oVjQmDvMe8kqawF0emwKZZQw04y8vmaVAXXBGIitYzObGPCGEPKCAGTkWcu6-asEYwLgrs5If4GpC3NZvFOPjlNKboWb64Va_4_3viD38GtpygD7kqxOx7P4ChybqdtIGwJw_TxkG0l2rwAvKPfC
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Beh%C3%A7et%27s+Disease%3A+An+Overview+of+Etiopathogenesis&rft.jtitle=Frontiers+in+immunology&rft.au=Leccese%2C+Pietro&rft.au=Alpsoy%2C+Erkan&rft.date=2019-05-10&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=10&rft.spage=1067&rft_id=info:doi/10.3389%2Ffimmu.2019.01067&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon